Paper published in a journal (Scientific congresses and symposiums)
Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis : 1-year results from mobile
Cooper, C.; Stepan, J. J.; Lorenc, R. et al.
2005In BONE, 36 (S2), p. 417
Peer Reviewed verified by ORBi
 

Files


Full Text
MONTHLY ORAL IBANDRONATE IS AT LEAST AS EFFECTIVE AS DAILY ORAL IBANDRONATE IN INCREASING HIP BMD IN POSTMENOPAUSAL OSTEOPOROSIS.pdf
Publisher postprint (200.23 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
General & internal medicine
Author, co-author :
Cooper, C.
Stepan, J. J.
Lorenc, R.
Hughes, C.
Coutant, K.
Sedarati, F.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Monthly oral ibandronate is at least as effective as daily oral ibandronate in increasing hip BMD in postmenopausal osteoporosis : 1-year results from mobile
Publication date :
2005
Event name :
2nd Joint Meeting 2005
Event organizer :
European Calcified Tissue Society and the International Bone and Mineral Society
Event place :
Geneva, Switzerland
Event date :
Du 25 au 29 juin 2005
Audience :
International
Journal title :
BONE
ISSN :
8756-3282
eISSN :
1873-2763
Publisher :
Elsevier Science, New York, United States - New York
Volume :
36
Issue :
S2
Pages :
S417
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 14 February 2012

Statistics


Number of views
19 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi